BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31530106)

  • 1. Synchronous presentation of tuberculosis and hepatocellular carcinoma in a cirrhotic patient: a case report.
    Shah D; P G; S S; Koushik AK
    Trop Doct; 2020 Jan; 50(1):71-74. PubMed ID: 31530106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of intraabdominal tuberculous lymphadenopathy after drug-eluting beads transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma.
    Murata Y; Hiramatsu K; Yoshida Y; Akazawa Y; Saito Y; Nosaka T; Ozaki Y; Hayama R; Takahashi K; Naito T; Ofuji K; Matsuda H; Ohtani M; Nemoto T; Nakamoto Y
    Clin J Gastroenterol; 2019 Feb; 12(1):76-81. PubMed ID: 30141183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors of transarterial chemoembolisation toxicity in unresectable hepatocellular carcinoma.
    Boulin M; Adam H; Guiu B; Aho LS; Cercueil JP; Di Martino C; Fagnoni P; Minello A; Jouve JL; Hillon P; Bedenne L; Lepage C
    Dig Liver Dis; 2014 Apr; 46(4):358-62. PubMed ID: 24462550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular pseudotumor in the cirrhotic liver. Report of three cases.
    Nagasue N; Akamizu H; Yukaya H; Yuuki I
    Cancer; 1984 Dec; 54(11):2487-94. PubMed ID: 6093981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-existence of hepatocellular carcinoma and hepatic tuberculosis.
    Limaiem F; Gargouri F; Bouraoui S; Lahmar A; Mzabi S
    Surg Infect (Larchmt); 2014 Aug; 15(4):437-40. PubMed ID: 24476016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.
    Romano A; Angeli P; Piovesan S; Noventa F; Anastassopoulos G; Chemello L; Cavalletto L; Gambato M; Russo FP; Burra P; Vincenzi V; Scotton PG; Panese S; Tempesta D; Bertin T; Carrara M; Carlotto A; Capra F; Carolo G; Scroccaro G; Alberti A
    J Hepatol; 2018 Aug; 69(2):345-352. PubMed ID: 29551707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology of hepatocellular carcinoma.
    Paradis V
    Recent Results Cancer Res; 2013; 190():21-32. PubMed ID: 22941011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hepatocellular carcinoma occurring in a cirrhotic liver--laparoscopically confirmed transition from a cirrhotic nodule to a hepatocellular carcinoma at an interval of 10 months.
    Iwamura K; Hirayama S; Inaba R; Golebiowski M
    Tokai J Exp Clin Med; 1984 Mar; 9(1):69-79. PubMed ID: 6100145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
    Antoniou E; Mantas D; Paraskeva P; Dimitroulis D; Smyrnis A; Nikitakis N; Labadariou A; Tsavaris N; Vernicos P; Kostakis A
    Transplant Proc; 2012 Nov; 44(9):2745-7. PubMed ID: 23146511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of hepatocellular carcinoma with liver cirrhosis type C surviving over 2 years by repeated transarterial infusion therapy using cisplatinum].
    Miura T; Tsuboi Y; Takano T; Ozeki Y; Nakamura J; Yamada S; Miura T; Yanagi M; Takahashi T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1347-9. PubMed ID: 19692776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of HCC in asymptomatic HCV-related chronic hepatitis.
    Persico M; Palmentieri B; Coppola L; Di Giacomo Russo G; De Marino F; De Sio I; Torella R
    Dig Dis Sci; 2002 Nov; 47(11):2407-10. PubMed ID: 12452370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segment VI HCC on HCV related cirrhosis treated by laparoscopic resection (with video).
    Brustia R; Soubrane O
    J Visc Surg; 2016 Feb; 153(1):69-70. PubMed ID: 26797568
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease.
    Mobarak L; Omran D; Nabeel MM; Zakaria Z
    J Med Virol; 2017 Jun; 89(6):1062-1068. PubMed ID: 27769108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic and intraperitoneal splenosis mimicking hepatocellular carcinoma with abdominal wall metastasis in a patient with hepatitis C cirrhotic liver.
    Li T; Yang XY; Tang ZY
    Surgery; 2015 May; 157(5):954-6. PubMed ID: 25934025
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature review.
    Leone N; Volpes R; Carrera M; Pellicano R; De Paolis P; Fiorentino M; Fronda GR; Rizzetto M
    Panminerva Med; 2000 Jun; 42(2):151-4. PubMed ID: 10965777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
    Waziry R; Gomaa A; Waked I; Dore GJ
    Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.